MedPage Today on MSN
Expand Labeling for Testosterone Replacement Therapy, FDA Panel Says
Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...
MedPage Today on MSN
Cardiologists on Board With FDA's Proposed Food Package Labels
The FDA's proposed rule would require food manufacturers to put "Nutrition Info" boxes on the front of their packages stating ...
In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...
Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...
AS FAMILIES prepare for the holiday season, the Food and Drug Administration (FDA) on Friday, Dec. 5, 2025, urged consumers ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
As families prepare for the holiday season, the Food and Drug Administration (FDA) on Friday urged consumers to carefully ...
An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.
The medtech giant said the approval marks a shift from humanitarian device exemption (HDE) status to full effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results